D.E. Shaw & Co’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Hold |
0
| – | – | – | 4640 |
|
|
2025
Q4 | – | Hold |
0
| – | – | – | 4667 |
|
|
2025
Q3 | – | Hold |
0
| – | – | – | 4633 |
|
|
2025
Q2 | – | Hold |
0
| – | – | – | 4426 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 4356 |
|
|
2024
Q4 | – | Sell |
-29,365
| Closed | -$1.39M | – | 4489 |
|
|
2024
Q3 | $1.38M | Buy |
29,365
+1,191
| +4% | +$60.4K | ﹤0.01% | 3014 |
|
|
2024
Q2 | $1.52M | Sell |
28,174
-146,121
| -84% | -$8.45M | ﹤0.01% | 2895 |
|
|
2024
Q1 | $11.9M | Buy |
174,295
+137,023
| +368% | +$9.81M | 0.02% | 1258 |
|
|
2023
Q4 | $2.33M | Buy |
+37,272
| New | +$2.06M | ﹤0.01% | 2545 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 4307 |
|
|
2023
Q2 | – | Sell |
-4,600
| Closed | -$261K | – | 4305 |
|
|
2023
Q1 | $208K | Sell |
4,600
-9,300
| -67% | -$452K | ﹤0.01% | 3889 |
|
|
2022
Q4 | $565K | Buy |
+13,900
| New | +$737K | ﹤0.01% | 3789 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 5254 |
|
|
2022
Q2 | – | Sell |
-37,620
| Closed | -$2.21M | – | 5408 |
|
|
2022
Q1 | $2.36M | Buy |
37,620
+14,448
| +62% | +$907K | ﹤0.01% | 3150 |
|
|
2021
Q4 | $1.76M | Sell |
23,172
-11,524
| -33% | -$1.01M | ﹤0.01% | 3470 |
|
|
2021
Q3 | $3.88M | Buy |
34,696
+9,798
| +39% | +$1.23M | 0.01% | 2365 |
|
|
2021
Q2 | $4.03M | Sell |
24,898
-52,294
| -68% | -$6.36M | ﹤0.01% | 2235 |
|
|
2021
Q1 | $9.41M | Sell |
77,192
-205,959
| -73% | -$31.1M | 0.01% | 1401 |
|
|
2020
Q4 | $43.4M | Buy |
283,151
+16,284
| +6% | +$1.92M | 0.05% | 563 |
|
|
2020
Q3 | $22.3M | Sell |
266,867
-61,757
| -19% | -$5.48M | 0.03% | 774 |
|
|
2020
Q2 | $24.1M | Buy |
328,624
+52,765
| +19% | +$3.09M | 0.04% | 681 |
|
|
2020
Q1 | $11.7M | Buy |
275,859
+267,192
| +3,083% | +$13.8M | 0.02% | 907 |
|
|
2019
Q4 | $528K | Sell |
8,667
-11,417
| -57% | -$623K | ﹤0.01% | 3366 |
|
|
2019
Q3 | $823K | Buy |
20,084
+13,065
| +186% | +$624K | ﹤0.01% | 2926 |
|
|
2019
Q2 | $331K | Buy |
7,019
+467
| +7% | +$18.7K | ﹤0.01% | 3273 |
|
|
2019
Q1 | $234K | Sell |
6,552
-18,160
| -73% | -$628K | ﹤0.01% | 3335 |
|
|
2018
Q4 | $706K | Buy |
24,712
+19,177
| +346% | +$667K | ﹤0.01% | 2890 |
|
|
2018
Q3 | $245K | Sell |
5,535
-152
| -3% | -$7.96K | ﹤0.01% | 3448 |
|
|
2018
Q2 | $334K | Sell |
5,687
-10,308
| -64% | -$587K | ﹤0.01% | 3324 |
|
|
2018
Q1 | $731K | Buy |
+15,995
| New | +$660K | ﹤0.01% | 2697 |
|
Other funds holding CRSP
AIM
OAG
GP
SOCM
